Skip to main content
. Author manuscript; available in PMC: 2013 Dec 22.
Published in final edited form as: Mol Pharm. 2012 Jun 22;9(8):2280–2289. doi: 10.1021/mp300152v

Table 2.

Serum levels of ALT, AST and BUN after long-term treatment with therapeutic siRNA in the targeted LCP

ALT (U/L) AST (U/L) BUN (mg/dL)
Untreated group 55.5 ± 9.12 140.5 ± 10.61 16 ± 2.83
Therapeutic siRNA in targeted LCP treated group 58.33 ±17.5 149.33 ± 24.91 20 ± 5.29

Measurements were carried out with the aim of evaluating the potential long-term toxicity of pooled siRNA in the targeted LCP. Data = mean ± SD (n = 5).